{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T23:22:28Z","timestamp":1789946548131,"version":"4.0.1"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,7,14]],"date-time":"2017-07-14T00:00:00Z","timestamp":1499990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,7,14]],"date-time":"2017-07-14T00:00:00Z","timestamp":1499990400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Recent studies have reported of an association between high serum apolipoprotein A1 (APOA1) levels and favorable prognosis in several malignancies, while the significance of apolipoprotein B (APOB) in cancer is less well-known. In this study, we analyzed the correlation between serum APOA1 and APOB levels, and APOB\/APOA1 ratio, and their associations with clinicopathologic parameters, the levels of twenty systemic inflammatory markers, and survival in 144 colorectal cancer (CRC) patients. We demonstrated that low serum APOA1 levels associated with advanced T-class and TNM-stage but low serum APOB levels did not significantly correlate with tumor characteristics. Serum APOA1 levels showed strong negative correlation with the markers of systemic inflammation including serum CRP and interleukin (IL)-8 levels and blood neutrophil count, whereas high serum APOB levels associated with high serum CCL2 levels. High APOA1 and APOB levels and low APOB\/APOA1 ratio associated with improved cancer specific and overall survival. APOA1 had independent prognostic value in Cox regression analysis. In conclusion, low serum APOA1 levels are associated with advanced stage and systemic inflammation, while serum APOB does not significantly correlate with tumor stage. Serum APOA1 represents a promising additional prognostic parameter in CRC.<\/jats:p>","DOI":"10.1038\/s41598-017-05415-9","type":"journal-article","created":{"date-parts":[[2017,7,10]],"date-time":"2017-07-10T08:37:54Z","timestamp":1499675874000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":68,"title":["Decreased serum apolipoprotein A1 levels are associated with poor survival and systemic inflammatory response in colorectal cancer"],"prefix":"10.1038","volume":"7","author":[{"given":"P\u00e4ivi","family":"Sirni\u00f6","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juha P.","family":"V\u00e4yrynen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Klintrup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jyrki","family":"M\u00e4kel\u00e4","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus J.","family":"M\u00e4kinen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tuomo J.","family":"Karttunen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Tuomisto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,7,14]]},"reference":[{"key":"5415_CR1","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1002\/emmm.201200224","volume":"4","author":"C Besler","year":"2012","unstructured":"Besler, C., L\u00fcscher, T. F. & Landmesser, U. Molecular mechanisms of vascular effects of High-density lipoprotein: alterations in cardiovascular disease. EMBO Mol. Med. \n                           4, 251\u201368 (2012).","journal-title":"EMBO Mol. Med."},{"key":"5415_CR2","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1161\/01.ATV.0000075912.83860.26","volume":"23","author":"N Wang","year":"2003","unstructured":"Wang, N. & Tall, A. R. Regulation and mechanisms of ATP-binding cassette transporter A1-mediated cellular cholesterol efflux. Arterioscler. Thromb. Vasc. Biol. \n                           23, 1178\u201384 (2003).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"5415_CR3","doi-asserted-by":"publisher","first-page":"113","DOI":"10.2217\/17584299.4.1.113","volume":"4","author":"MG Sorci-Thomas","year":"2009","unstructured":"Sorci-Thomas, M. G., Bhat, S. & Thomas, M. J. Activation of lecithin:cholesterol acyltransferase by HDL ApoA-I central helices. Clin. Lipidol. \n                           4, 113\u2013124 (2009).","journal-title":"Clin. Lipidol."},{"key":"5415_CR4","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1093\/oxfordjournals.aje.a115483","volume":"131","author":"DR Jacobs","year":"1990","unstructured":"Jacobs, D. R., Mebane, I. L., Bangdiwala, S. I., Criqui, M. H. & Tyroler, H. A. High density lipoprotein cholesterol as a predictor of cardiovascular disease mortality in men and women: the follow-up study of the Lipid Research Clinics Prevalence Study. Am. J. Epidemiol. \n                           131, 32\u201347 (1990).","journal-title":"Am. J. Epidemiol."},{"key":"5415_CR5","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/0002-9343(77)90874-9","volume":"62","author":"T Gordon","year":"1977","unstructured":"Gordon, T., Castelli, W. P., Hjortland, M. C., Kannel, W. B. & Dawber, T. R. High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study. Am. J. Med. \n                           62, 707\u201314 (1977).","journal-title":"Am. J. Med."},{"key":"5415_CR6","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/S0002-9149(00)01464-8","volume":"86","author":"WE Boden","year":"2000","unstructured":"Boden, W. E. High-density lipoprotein cholesterol as an independent risk factor in cardiovascular disease: assessing the data from framingham to the veterans affairs high-density lipoprotein intervention trial. Am. J. Cardiol. \n                           86, 19\u201322 (2000).","journal-title":"Am. J. Cardiol."},{"key":"5415_CR7","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/j.ahj.2004.03.021","volume":"148","author":"K Dunder","year":"2004","unstructured":"Dunder, K., Lind, L., Zethelius, B., Berglund, L. & Lithell, H. Evaluation of a scoring scheme, including proinsulin and the apolipoprotein B\/apolipoprotein A1 ratio, for the risk of acute coronary events in middle-aged men: Uppsala Longitudinal Study of Adult Men (ULSAM). Am. Heart J. \n                           148, 596\u2013601 (2004).","journal-title":"Am. Heart J."},{"key":"5415_CR8","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.numecd.2009.11.002","volume":"21","author":"GP Carnevale Schianca","year":"2011","unstructured":"Carnevale Schianca, G. P. et al. ApoB\/apoA-I ratio is better than LDL-C in detecting cardiovascular risk. Nutr. Metab. Cardiovasc. Dis. \n                           21, 406\u2013411 (2011).","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"5415_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2015\/591454","volume":"2015","author":"AM Kaneva","year":"2015","unstructured":"Kaneva, A. M., Potolitsyna, N. N., Bojko, E. R. & Odland, J. \u00d8. The Apolipoprotein B\/Apolipoprotein A-I Ratio as a Potential Marker of Plasma Atherogenicity. Dis. Markers \n                           2015, 1\u20137 (2015).","journal-title":"Dis. Markers"},{"key":"5415_CR10","doi-asserted-by":"crossref","unstructured":"Siegel, R., Ma, J., Zou, Z. & Jemal, A. Cancer statistics, CA. Cancer J. Clin. 64, 9\u201329 (2014).","DOI":"10.3322\/caac.21208"},{"key":"5415_CR11","doi-asserted-by":"publisher","unstructured":"Borgquist, S. et al. Apo-lipoproteins, lipids and risk of cancer. Int. J. Cancer doi:10.1002\/ijc.30013 (2016).","DOI":"10.1002\/ijc.30013"},{"key":"5415_CR12","doi-asserted-by":"publisher","first-page":"2814","DOI":"10.1158\/1055-9965.EPI-08-1248","volume":"18","author":"J Ahn","year":"2009","unstructured":"Ahn, J. et al. Prediagnostic Total and High-Density Lipoprotein Cholesterol and Risk of Cancer. Cancer Epidemiol. Biomarkers Prev. \n                           18, 2814\u20132821 (2009).","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"5415_CR13","doi-asserted-by":"publisher","first-page":"2846","DOI":"10.1016\/j.jacc.2009.12.069","volume":"55","author":"H Jafri","year":"2010","unstructured":"Jafri, H., Alsheikh-Ali, A. A. & Karas, R. H. Baseline and On-Treatment High-Density Lipoprotein Cholesterol and the Risk of Cancer in Randomized Controlled Trials of Lipid-Altering Therapy. J. Am. Coll. Cardiol. \n                           55, 2846\u20132854 (2010).","journal-title":"J. Am. Coll. Cardiol."},{"key":"5415_CR14","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1007\/s10552-015-0555-y","volume":"26","author":"J-A Coppola","year":"2015","unstructured":"Coppola, J.-A. et al. Plasma lipid levels and colorectal adenoma risk. Cancer Causes Control \n                           26, 635\u201343 (2015).","journal-title":"Cancer Causes Control"},{"key":"5415_CR15","doi-asserted-by":"publisher","first-page":"3355","DOI":"10.1017\/S1368980015000646","volume":"18","author":"Y Tian","year":"2015","unstructured":"Tian, Y. et al. The association between serum lipids and colorectal neoplasm: a systemic review and meta-analysis. Public Health Nutr. \n                           18, 3355\u201370 (2015).","journal-title":"Public Health Nutr."},{"key":"5415_CR16","doi-asserted-by":"publisher","first-page":"481","DOI":"10.7326\/0003-4819-118-7-199304010-00001","volume":"118","author":"E Bayerd\u00f6rffer","year":"1993","unstructured":"Bayerd\u00f6rffer, E. et al. Decreased high-density lipoprotein cholesterol and increased low-density cholesterol levels in patients with colorectal adenomas. Ann. Intern. Med. \n                           118, 481\u20137 (1993).","journal-title":"Ann. Intern. Med."},{"key":"5415_CR17","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/s10654-014-9901-8","volume":"29","author":"K Aleksandrova","year":"2014","unstructured":"Aleksandrova, K. et al. Biomarker patterns of inflammatory and metabolic pathways are associated with risk of colorectal cancer: results from the European Prospective Investigation into Cancer and Nutrition (EPIC). Eur. J. Epidemiol. \n                           29, 261\u201375 (2014).","journal-title":"Eur. J. Epidemiol."},{"key":"5415_CR18","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1136\/gut.2010.225011","volume":"60","author":"FJB Van Duijnhoven","year":"2011","unstructured":"Van Duijnhoven, F. J. B. et al. Blood lipid and lipoprotein concentrations and colorectal cancer risk in the European Prospective Investigation into Cancer and Nutrition. Gut \n                           60, 1094\u2013102 (2011).","journal-title":"Gut"},{"key":"5415_CR19","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.jprot.2016.07.031","volume":"148","author":"J Peltier","year":"2016","unstructured":"Peltier, J., Roperch, J.-P., Audebert, S., Borg, J.-P. & Camoin, L. Quantitative proteomic analysis exploring progression of colorectal cancer: Modulation of the serpin family. J. Proteomics \n                           148, 139\u201348 (2016).","journal-title":"J. Proteomics"},{"key":"5415_CR20","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.3748\/wjg.v12.i10.1536","volume":"12","author":"JYMN Engwegen","year":"2006","unstructured":"Engwegen, J. Y. M. N. et al. Identification of serum proteins discriminating colorectal cancer patients and healthy controls using surface-enhanced laser desorption ionisation-time of flight mass spectrometry. World J. Gastroenterol. \n                           12, 1536\u201344 (2006).","journal-title":"World J. Gastroenterol."},{"key":"5415_CR21","doi-asserted-by":"crossref","first-page":"44037","DOI":"10.18632\/oncotarget.5823","volume":"6","author":"X Luo","year":"2015","unstructured":"Luo, X. et al. Serum apolipoprotein A-I is a novel prognostic indicator for non-metastatic nasopharyngeal carcinoma. Oncotarget \n                           6, 44037\u201348 (2015).","journal-title":"Oncotarget"},{"key":"5415_CR22","doi-asserted-by":"publisher","first-page":"265","DOI":"10.3389\/fphar.2015.00265","volume":"6","author":"M Zamanian-Daryoush","year":"2015","unstructured":"Zamanian-Daryoush, M. & DiDonato, J. A. Apolipoprotein A-I and Cancer. Front. Pharmacol. \n                           6, 265 (2015).","journal-title":"Front. Pharmacol."},{"key":"5415_CR23","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/j.atherosclerosis.2012.11.024","volume":"226","author":"J-H Ryoo","year":"2013","unstructured":"Ryoo, J.-H. & Park, S. K. Association of apolipoprotein B and incidence of metabolic syndrome in Korean men: A 5-years\u2019 follow-up study. Atherosclerosis \n                           226, 496\u2013501 (2013).","journal-title":"Atherosclerosis"},{"key":"5415_CR24","doi-asserted-by":"publisher","first-page":"E2050","DOI":"10.1210\/jc.2011-1857","volume":"96","author":"MH Seo","year":"2011","unstructured":"Seo, M. H. et al. Association of Lipid and Lipoprotein Profiles with Future Development of Type 2 Diabetes in Nondiabetic Korean Subjects: A 4-Year Retrospective, Longitudinal Study. J. Clin. Endocrinol. Metab. \n                           96, E2050\u2013E2054 (2011).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"5415_CR25","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.2353\/ajpath.2006.051090","volume":"169","author":"S Cowey","year":"2006","unstructured":"Cowey, S. & Hardy, R. W. The Metabolic Syndrome. Am. J. Pathol. \n                           169, 1505\u20131522 (2006).","journal-title":"Am. J. Pathol."},{"key":"5415_CR26","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1002\/ijc.25362","volume":"128","author":"EA Atchison","year":"2011","unstructured":"Atchison, E. A., Gridley, G., Carreon, J. D., Leitzmann, M. F. & McGlynn, K. A. Risk of cancer in a large cohort of U.S. veterans with diabetes. Int. J. Cancer \n                           128, 635\u2013643 (2011).","journal-title":"Int. J. Cancer"},{"key":"5415_CR27","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1038\/bjc.2012.456","volume":"107","author":"T Kantola","year":"2012","unstructured":"Kantola, T. et al. Stage-dependent alterations of the serum cytokine pattern in colorectal carcinoma. Br. J. Cancer \n                           107, 1729\u201336 (2012).","journal-title":"Br. J. Cancer"},{"key":"5415_CR28","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/j.ctrv.2012.08.003","volume":"39","author":"DC McMillan","year":"2013","unstructured":"McMillan, D. C. The systemic inflammation-based Glasgow Prognostic Score: a decade of experience in patients with cancer. Cancer Treat. Rev. \n                           39, 534\u201340 (2013).","journal-title":"Cancer Treat. Rev."},{"key":"5415_CR29","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1038\/bjc.2013.162","volume":"108","author":"T Kantola","year":"2013","unstructured":"Kantola, T. et al. Reply: Comment on \u2018Stage-dependent alterations of the serum cytokine pattern in colorectal carcinoma\u2019. Br. J. Cancer \n                           108, 1917\u20138 (2013).","journal-title":"Br. J. Cancer"},{"key":"5415_CR30","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1002\/ijc.30040","volume":"139","author":"JP V\u00e4yrynen","year":"2016","unstructured":"V\u00e4yrynen, J. P. et al. The relationships between serum cytokine levels and tumor infiltrating immune cells and their clinical significance in colorectal cancer. Int. J. Cancer \n                           139, 112\u2013121 (2016).","journal-title":"Int. J. Cancer"},{"key":"5415_CR31","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1194\/jlr.E005454","volume":"51","author":"KR Feingold","year":"2010","unstructured":"Feingold, K. R. & Grunfeld, C. The acute phase response inhibits reverse cholesterol transport. J. Lipid Res. \n                           51, 682\u20134 (2010).","journal-title":"J. Lipid Res."},{"key":"5415_CR32","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1038\/ncb3015","volume":"16","author":"SS McAllister","year":"2014","unstructured":"McAllister, S. S. & Weinberg, R. A. The tumour-induced systemic environment as a critical regulator of cancer progression and metastasis. Nat. Cell Biol. \n                           16, 717\u2013727 (2014).","journal-title":"Nat. Cell Biol."},{"key":"5415_CR33","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.bbagen.2003.08.004","volume":"1623","author":"MJ Haas","year":"2003","unstructured":"Haas, M. J. et al. Suppression of apolipoprotein AI gene expression in HepG2 cells by TNF alpha and IL-1beta. Biochim. Biophys. Acta \n                           1623, 120\u20138 (2003).","journal-title":"Biochim. Biophys. Acta"},{"key":"5415_CR34","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1007\/s00125-006-0259-7","volume":"49","author":"M Faraj","year":"2006","unstructured":"Faraj, M. et al. Apolipoprotein B: a predictor of inflammatory status in postmenopausal overweight and obese women. Diabetologia \n                           49, 1637\u20131646 (2006).","journal-title":"Diabetologia"},{"key":"5415_CR35","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1007\/s12020-012-9599-x","volume":"42","author":"W Xu","year":"2012","unstructured":"Xu, W. et al. The relationship between high-sensitivity C-reactive protein and ApoB, ApoB\/ApoA1 ratio in general population of China. Endocrine \n                           42, 132\u2013138 (2012).","journal-title":"Endocrine"},{"key":"5415_CR36","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1056\/NEJM199902113400607","volume":"340","author":"C Gabay","year":"1999","unstructured":"Gabay, C. & Kushner, I. Acute-phase proteins and other systemic responses to inflammation. N. Engl. J. Med. \n                           340, 448\u2013454 (1999).","journal-title":"N. Engl. J. Med."},{"key":"5415_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.atherosclerosis.2005.08.008","volume":"184","author":"G Ferretti","year":"2006","unstructured":"Ferretti, G. et al. Structural modifications of HDL and functional consequences. Atherosclerosis \n                           184, 1\u20137 (2006).","journal-title":"Atherosclerosis"},{"key":"5415_CR38","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1038\/bjc.2016.128","volume":"114","author":"SA V\u00e4yrynen","year":"2016","unstructured":"V\u00e4yrynen, S. A. et al. Clinical impact and network of determinants of tumour necrosis in colorectal cancer. Br. J. Cancer \n                           114, 1334\u20131342 (2016).","journal-title":"Br. J. Cancer"},{"key":"5415_CR39","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/bjc.2013.291","volume":"109","author":"GJK Guthrie","year":"2013","unstructured":"Guthrie, G. J. K., Roxburgh, C. S. D., Richards, C. H., Horgan, P. G. & McMillan, D. C. Circulating IL-6 concentrations link tumour necrosis and systemic and local inflammatory responses in patients undergoing resection for colorectal cancer. Br. J. Cancer \n                           109, 131\u20137 (2013).","journal-title":"Br. J. Cancer"},{"key":"5415_CR40","first-page":"74","volume":"27","author":"A Panayiotou","year":"2008","unstructured":"Panayiotou, A. et al. ApoB\/ApoA1 ratio and subclinical atherosclerosis. Int. Angiol. \n                           27, 74\u201380 (2008).","journal-title":"Int. Angiol."},{"key":"5415_CR41","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1177\/1066896906293348","volume":"14","author":"B Kruslin","year":"2006","unstructured":"Kruslin, B. et al. The correlation between the tumor necrosis and renal artery changes in renal cell carcinoma. Int. J. Surg. Pathol. \n                           14, 312\u20139 (2006).","journal-title":"Int. J. Surg. Pathol."},{"key":"5415_CR42","doi-asserted-by":"publisher","first-page":"e40878","DOI":"10.1371\/journal.pone.0040878","volume":"7","author":"G Tognon","year":"2012","unstructured":"Tognon, G. et al. Comparison of apolipoprotein (apoB\/apoA-I) and lipoprotein (total cholesterol\/HDL) ratio determinants. Focus on obesity, diet and alcohol intake. PLoS One \n                           7, e40878 (2012).","journal-title":"PLoS One"},{"key":"5415_CR43","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1038\/bjc.2014.456","volume":"111","author":"T Kantola","year":"2014","unstructured":"Kantola, T. et al. Serum endostatin levels are elevated in colorectal cancer and correlate with invasion and systemic inflammatory markers. Br. J. Cancer \n                           111, 1605\u201313 (2014).","journal-title":"Br. J. Cancer"},{"key":"5415_CR44","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.humpath.2014.11.020","volume":"46","author":"JM Moilanen","year":"2015","unstructured":"Moilanen, J. M. et al. Collagen XVII expression correlates with the invasion and metastasis of colorectal cancer. Hum. Pathol. \n                           46, 434\u2013442 (2015).","journal-title":"Hum. Pathol."},{"key":"5415_CR45","doi-asserted-by":"crossref","unstructured":"Sobin, L. H. & Wittekind, C. TNM classification of malignant tumours. 6, (Wiley-Liss, 2002).","DOI":"10.1002\/0471463752"},{"key":"5415_CR46","unstructured":"Hamilton, S. R. et al. in WHO classification of tumours of the digestive system. (eds Bosman, F., Carneiro, F., Hruban, R. & Theise, N.) 134\u2013146 (IARC Press, 2010)."},{"key":"5415_CR47","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1161\/CIRCGENETICS.114.000216","volume":"8","author":"P Soininen","year":"2015","unstructured":"Soininen, P., Kangas, A. J., W\u00fcrtz, P., Suna, T. & Ala-Korpela, M. Quantitative serum nuclear magnetic resonance metabolomics in cardiovascular epidemiology and genetics. Circ. Cardiovasc. Genet. \n                           8, 192\u2013206 (2015).","journal-title":"Circ. Cardiovasc. Genet."},{"key":"5415_CR48","doi-asserted-by":"publisher","first-page":"E463","DOI":"10.1002\/ijc.26435","volume":"131","author":"JP V\u00e4yrynen","year":"2012","unstructured":"V\u00e4yrynen, J. P. et al. Serum MMP-8 levels increase in colorectal cancer and correlate with disease course and inflammatory properties of primary tumors. Int. J. Cancer \n                           131, E463\u201374 (2012).","journal-title":"Int. J. Cancer"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-05415-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-05415-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-05415-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T06:45:23Z","timestamp":1671777923000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-05415-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,14]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["5415"],"URL":"https:\/\/doi.org\/10.1038\/s41598-017-05415-9","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,14]]},"assertion":[{"value":"14 December 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"5374"}}